OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Autoimmunity is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	396
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	226
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	188
GILZ regulates type I interferon release and sequesters STAT1	142
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	123
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	122
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	104
Advances in SLE classification criteria	103
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	95
Editorial Board	95
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	92
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	89
Lupus nephritis: new progress in diagnosis and treatment	89
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	80
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	77
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	76
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	76
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	75
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases	75
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	74
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	70
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	67
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	64
Glycobiology of psoriasis: A review	61
Editorial Board	60

Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	60
Editorial Board	57
Editorial Board	56
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	55
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	54
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	53
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	50
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	48
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	48
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	45
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation	44
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	43
Antigenic mimicry – The key to autoimmunity in immune privileged organs	40
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	40
The complement system and human autoimmune diseases	40
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	40
Editorial Board	39
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis	39
LAT1 enables T cell activation under inflammatory conditions	39
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje	39
Familial patterns of alopecia areata: A systematic review and meta-analysis	36
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study	36
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis	36
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach	35
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review	33
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis	32
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis	31
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis	31
The role of gut flora-driven Th cell responses in preclinical rheumatoid arthritis	30
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study	30
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis	30
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy	30
Pregnancy-related complications in systemic lupus erythematosus	29
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation	29
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	28
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	27
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	27
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice	26
T cell aging as a risk factor for autoimmunity	26
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	26
Interferon signature in giant cell arteritis aortitis	25
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study	25
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity	25
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis	25
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review	24
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?	24
Environmental exposures as risk factors for idiopathic inflammatory myopathies	24
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study	23
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study	23
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis	23

Recent advances in cutaneous lupus	23
Editorial Board	23
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients	23
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease	23
Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation	22
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis	22
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening	22
Extracellular vesicle autoantibodies	21
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases	21
Interleukin-15 is a hair follicle immune privilege guardian	21
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice	21
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	21
Natural IgG protects against early dissemination of vesicular stomatitis virus	20
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome	20
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	20
T follicular helper cells in autoimmune diseases	20
RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation	20
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	20
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	19
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	19
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	19
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	19
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	18
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	18
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	18
Application of laboratory models for sarcoidosis research	18
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	18
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	18
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape	18
Telomeres: New players in immune-mediated inflammatory diseases?	18
PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis	17
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	17
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	17
Corrigendum to “Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies” [J. Autoimmun. 126 (2022) 102774]	17
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	17
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	17
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	17
Developmental drugs for sarcoidosis	16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	16
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	16
Outcome and prognosis of isolated carotid vasculitis	16
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	16
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	16
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis	16
Cognitive dysfunction in SLE: An understudied clinical manifestation	16
Treatment of mixed connective tissue disease: A multicenter retrospective study	16
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	16
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement	15
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	15
Autophagy pathways in autoimmune diseases	15
Autoimmune hepatitis following COVID-19 vaccination	15
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis	15
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production	15
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype	15
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis	15
Pre-existing conditions associated with post-acute sequelae of COVID-19	14
B cell-specific mAb–siRNA conjugates improve experimental myasthenia	14
Diversity and function of regulatory T cells in health and autoimmune diseases	14
Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus	14
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	14
PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis	14
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review	14
Flagellin-specific human CAR Tregs for immune regulation in IBD	14
Editorial Board	14
Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study	14
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency	14